Andhra Pradesh Scales Up HPV Vaccination Drive to Combat Cervical Cancer
Andhra Pradesh is significantly intensifying its efforts to protect adolescent girls from cervical cancer. The state government has received a substantial supply of Human Papillomavirus (HPV) vaccines from the central government, ensuring that a critical demographic of teenage girls receives essential preventive care.
Expanding Vaccine Supply and Distribution
The Andhra Pradesh government has now received a total of 3.81 lakh doses of the HPV vaccine, delivered by the central government in two distinct phases. According to reports, the first phase consisted of 1,90,800 doses, followed by a recent second consignment of 1,90,890 doses.
Health Minister Satya Kumar Yadav stated that this strategic supply is intended to ensure that all targeted girls are vaccinated by May, timed to follow the conclusion of Class X public examinations. As per central directives, 500 doses from the initial phase were allocated to Yanam.
Target Population and Current Progress
The vaccination drive specifically targets adolescent girls aged 14 to 15 years. Using data from village and ward secretariats, the state has identified 3.45 lakh eligible girls within this age group.
Current data indicates that the drive is gaining momentum:
- Total Vaccinated: 1,14,512 girls.
- Coverage Rate: Approximately 33.19% of the identified population.
District-Level Implementation and Infrastructure
To maintain the efficacy and safety of the vaccines, the drive is being conducted across 1,645 primary health centres and urban health centres. These facilities are equipped with necessary cold chain infrastructure for safe storage.
Vaccination rates vary across the state. According to official data, the administration numbers per district are as follows:
| District | Vaccinations Administered |
|---|---|
| Kurnool | 6,785 (Highest) |
| Nellore | 6,726 |
| YSR | 6,725 |
| Anantapur | 6,655 |
| Anakapalli | 2,959 |
| Sri Sathya Sai | 2,769 |
| Alluri Sitarama Raju (ASR) | 1,063 |
| Polavaram | 669 (Lowest) |
Safety and Efficacy
The HPV vaccine is recognized as a safe and effective primary preventive measure against cervical cancer. To ensure patient safety, health officials maintain a strict protocol where girls are kept under medical observation for 30 minutes following the administration of the vaccine. Minister Satya Kumar Yadav confirmed that no adverse reactions have been reported in the state to date.
Key Takeaways for Parents and Guardians
- Eligibility: The program is specifically for girls who have completed 14 years of age but are not yet 15.
- Goal: To prevent cervical cancer through early vaccination.
- Timeline: The program is expected to continue uninterrupted through May.
- Location: Vaccinations are available at designated primary and urban health centres with cold chain facilities.
Related reading